Pooja Patel
Physician Assistant · Woodburn, ORNPI 1962042556
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.1% of the total across 55 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $499 and has fallen 96.3% since, to $19 in 2024.
Across 55 payments — averaging $18.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$149
- Merck$133
- AstraZeneca$119
- Amgen$115
- Janssen Products, LP$99
- Novo Nordisk$57
- plus $325 from 13 others
Across 1 payment — averaging $39,650 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Astrazeneca UK Limited$40K
What the payments were for
- Food & beverage$89790%
- Education$9910%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 9 | $149 |
| Merck | 7 | $133 |
| AstraZeneca | 8 | $119 |
| Amgen(2 entities) | 8 | $115 |
| Janssen Products, LP | 1 | $99 |
| Novo Nordisk | 4 | $57 |
| Idorsia Pharmaceuticals US Inc | 2 | $45 |
| Xeris Pharmaceuticals, Inc. | 2 | $41 |
| GSK | 2 | $41 |
| Pfizer | 2 | $35 |
| Ironshore Pharmaceuticals Inc. | 2 | $30 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| Hologic Sales And Service, LLC | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Boehringer Ingelheim | 1 | $17 |
| Novartis | 1 | $17 |
| Exact Sciences | 1 | $14 |
| Dexcom, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$996 in reported general payments places this provider in the 80th percentile of 1,756 physician assistant providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $16,520 |
| JardianceEmpagliflozin | 12 | $16,225 |
| OzempicSemaglutide | 11 | $10,308 |
| Fluticasone Propionate | 12 | $1,329 |
| Gabapentin | 36 | $799 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $403 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $387 |
| Omeprazole | 23 | $369 |
| Atorvastatin Calcium | 40 | $367 |
| Levothyroxine Sodium | 27 | $338 |
| Alprazolam | 25 | $220 |
| Rosuvastatin Calcium | 11 | $219 |
| Oxycodone Hcl | 20 | $207 |
| Lisinopril | 42 | $181 |
| Lorazepam | 20 | $179 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $35 | $16,52016 claims |
| Boehringer IngelheimJardiance | $17 | $16,22512 claims |
| Novo NordiskOzempic | $57 | $10,30811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,756 physician assistant providers in Oregon.
Other physician assistant in Woodburn
- Devon ParksEugene$62K
- Ryan CainCorvallis$55K
- Sean BrownPortland$43K
- Meegan MangumPortland$25K
- Scott FrazeePortland$24K
- Marissa ReenEugene$15K
- Debra Allen KutcherMedford$14K
- Hanna TynerBend$12K
- Amanda VansantEugene$12K
- Christopher DavisMedford$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.